Group 1 - The article discusses the advancements in research on Amyotrophic Lateral Sclerosis (ALS) led by Don Cleveland, highlighting his contributions to understanding the disease's mechanisms and developing new therapies [2][3] - Cleveland emphasizes the importance of perseverance in scientific research, stating that intelligence and experimental skills are not the only keys to success; rather, persistence is essential [2][4] - The article mentions the potential of Antisense Oligonucleotide (ASO) therapy in treating genetic forms of ALS, with Cleveland noting that some progress has been made in reversing symptoms, although results are still not ideal [5][6] Group 2 - Cleveland expresses skepticism about the immediate impact of artificial intelligence (AI) in his field, acknowledging its potential but stressing the need for patience in drug testing and development [6][8] - He highlights the importance of rigorous clinical trials, stating that the effectiveness of ALS therapies can only be determined through long-term results [6][7] - The article reflects Cleveland's belief in the international nature of science, advocating for collaboration and competition to drive scientific progress, and noting China's significant investment in research [8][9]
美国神经生物学家与肿瘤学家唐·克利夫兰——坚持临床试验，与AI保持距离
Xin Lang Cai Jing·2025-12-22 10:07